Comparison between Original and Reviewed Consensus of European Working Group on Sarcopenia in Older People: A Probabilistic Cross-Sectional Survey among Community-Dwelling Older People.

Appendicular muscle mass EWGSOP EWGSOP2 Muscle mass Muscle strength Presarcopenia Probable sarcopenia Sarcopenia

Journal

Gerontology
ISSN: 1423-0003
Titre abrégé: Gerontology
Pays: Switzerland
ID NLM: 7601655

Informations de publication

Date de publication:
2022
Historique:
received: 21 05 2021
accepted: 29 08 2021
pubmed: 1 10 2021
medline: 5 8 2022
entrez: 30 9 2021
Statut: ppublish

Résumé

The European Working Group on Sarcopenia in Older People (EWGSOP) published a consensus on sarcopenia in 2010 and updated it in 2019 (EWGSOP2) which included the use of specific cut-off points. The aim was to assess how much prevalence of sarcopenia differed between EWGSOP2 and EWGSOP, as well as the use of specific cut-off points to assess differences in presarcopenia versus probable sarcopenia. Observational, transversal, and comparative study (n = 1,283 older adults; 57% women). Anthropometrics and handgrip strength were measured, and appendicular skeletal muscle mass equation was defined. Conceptual and methodological definitions of EWGSOP and EWGSOP2 consensus were applied to calculate prevalence of presarcopenia, probable sarcopenia, and sarcopenia. Using cut-off points recommended for European population, prevalence of sarcopenia with EWGSOP2 was lower (-6.6%; p < 0.001) than EWGSOP. The prevalence of probable sarcopenia (EWGSOP2) was higher (+7.8%; p < 0.001) than EWGSOP presarcopenia. The agreement between EGWGSOP and EWGSOP2 was moderated (K = 0.45; IC = 0.40-0.51). Using specific-population cut-off points for muscle strength and appendicular muscle mass, the prevalence of probable sarcopenia with EWGSOP2 was higher (46.5%; p < 0.001) than EWGSOP (1.8%). The agreement between EGWGSOP and EWGSOP2 was moderated (K = 0.48; IC = 0.42-0.52). The new EWGSOP2 consensus underestimates the prevalence of sarcopenia, compared with EWGSOP using conventional cut-off points. The prevalence of presarcopenia with EWGSOP (low muscle mass) was lower than probable sarcopenia (low muscle strength) with the new EWGSOP2. In both cases, agreements between EWGSOP2 and EWGSOP were moderated. Discrepancies between the original and new consensus have implications on the primary health setting for identifying old and new cases for prevention and treatment.

Identifiants

pubmed: 34592734
pii: 000519304
doi: 10.1159/000519304
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

869-876

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Erik Ramirez (E)

Body Composition Lab, Faculty of Public Health and Nutrition, Autonomous University of Nuevo Leon, Monterrey, Mexico.

Rogelio Salas (R)

Population Nutrition Laboratory, Faculty of Public Health and Nutrition, Autonomous University of Nuevo León, Monterrey, Mexico.

Cristina Bouzas (C)

CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands-IUNICS, & IDISBA, Palma de Mallorca, Spain.

Rosario Pastor (R)

Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands-IUNICS, & IDISBA, Palma de Mallorca, Spain.
Department of Human Nutrition & Dietetics, Faculty of Health Sciences, Catholic University of Avila, Avila, Spain.

Josep A Tur (JA)

CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands-IUNICS, & IDISBA, Palma de Mallorca, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH